Latest issue of Clinical laboratory
November 2025
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
Ziath releases new version of DP5 Network application for remote sample management
, /in Product News /by panglobalZiath has launched a new version of their popular DP5 Network application that enables tube barcode readers and scanners to be remote controlled from a smart phone or tablet via a Wi-Fi connection.
EUROIMMUN develops ELISAs for detection of anti-CCHFV antibodies for acute outbreak support
, /in Product News /by panglobalCrimean-Congo haemorrhagic fever (CCHF) is a life-threatening tick-borne viral disease which is included in the World Health Organisation priorities for research and product development for early diagnostics. Since there is no CCHF vaccine available, management of outbreaks relies on rapid identification of cases and appropriate infection control measures.
Owlstone partners with Bicycle Therapeutics to develop antigen-targeted EVOC Probes for early cancer detection
, /in E-News /by panglobalOwlstone Medical, the global leader in Breath Biopsy for applications in early disease detection and precision medicine, has entered into a Research Agreement with Bicycle Therapeutics, a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology.
Beckman Coulter and MeMed to expand access to host immune response diagnostic to distinguish between bacterial and viral infections
, /in E-News /by panglobalBeckman Coulter Diagnostics, a global leader in clinical diagnostics, and MeMed, a leader in the emerging field of advanced host-response technologies, have established a strategic partnership to jointly develop and commercialize the MeMed BV test, a host immune response diagnostic that is able to distinguish between bacterial and viral infections for use on the Access […]
Exothera appoints Darren Leva as Chief Business Officer
, /in E-News /by panglobalExothera, a full-service Contract Development and Manufacturing Organization (CDMO) specialized in gene therapy, vaccines, and oncolytic viruses, has appointed Darren Leva as Chief Business Officer. Darren’s extensive commercial experience in biotherapeutics CDMOs will further extend Exothera’s business and commercial capability across existing and brand-new markets.
Vetter joins UN Global Compact Network for sustainability
, /in E-News /by panglobalVetter has recently become a participant of the UN Global Compact Network (UN GC). Headquartered in Ravensburg, Germany, Vetter is a family-owned, global leading contract development and manufacturing organization (CDMO) with production facilities in Germany, Austria and the United States. The company has longterm experience in supporting biotechnology and pharmaceutical customers both large and small. […]
IIVS and Toxys agree to offer ToxTracker for in vitro genetic toxicity evaluation
, /in E-News /by panglobalThe Institute for In Vitro Sciences (IIVS) and Toxys have entered into a license agreement that allows IIVS to offer the ToxTracker assay. ToxTracker is an innovative in vitro assay allowing identification of the genotoxic and potentially carcinogenic properties of novel and existing drugs, (agro)chemicals, cosmetics and other substances without the use of animal testing.
Siemens Healthineers and Sysmex agree to supply haemostasis instruments, reagents as OEMs
, /in E-News /by panglobalSiemens Healthineers has signed a global OEM agreement on haemostasis products with Sysmex Corporation under which each company will supply the other with their products in the diagnostic field of haemostasis on an OEM basis.
ProBioGen makes three new appointments to support growth
, /in E-News /by panglobalProBioGen has seen significant growth with over 300 employees now working across its three locations in Berlin. In line with this growth, three crucial positions have been filled. Julian Collins has been appointed as Senior Vice President, Head of People & Organizational Development (P&OD) and a member of the Executive Team, while Dr Michiel Stork […]
Insight into clinical sample and consent tracking
, /in Featured Articles /by panglobalClinical specimens, clinical trial samples and the information associated with them are precious resources that require careful curation. CLI caught up with David Kaye [Vice President and General Manager of BioFortis (a Q2 Solutions company)] to find out more about what this entails.